Understanding anti thrombotic drugs
Upcoming SlideShare
Loading in...5
×
 

Understanding anti thrombotic drugs

on

  • 1,455 views

 

Statistics

Views

Total Views
1,455
Slideshare-icon Views on SlideShare
1,455
Embed Views
0

Actions

Likes
1
Downloads
38
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Understanding anti thrombotic drugs Understanding anti thrombotic drugs Presentation Transcript

    • Understanding Anti Thrombotic Drugs Steven Podnos MD
    • Arterial and Venous Thrombi are Different• Arterial Thrombi are composed of platelets bound by fibrin• Venous thrombi are composed of fibrin and trapped red blood cells, with rare platelets
    • What Drugs Work for Arterial vs. Venous Thrombi• Anti Platelet agents help with prevention and treatment of Arterial (but not Venous) Thrombosis• Anticoagulants help with prevention of BOTH Arterial and Venous Thrombosis
    • Anti Platelet Drugs• Used primarily for Primary and Secondary Prevention and Treatment of Acute Coronary Syndrome (angina, non STEMI, STEMI, PCI)
    • Anti Platelet Drugs -ASA• ASA-irreversible. Reduces risk of MI and death by 15-25% in patients with ACS• Slight benefit in prevention of MI in men and stroke in women as primary Rx.
    • Anti Platelet Drugs -Persantine• Dipyridamole-combined with ASA (Aggrenox) prevents vascular events in patients after TIA/minor stroke• High incidence of HA• Not better than Plavix alone
    • Thienopyridines-Plavix/Effient• Both irreversible blockers of platelet aggregation. Both have delayed onset• Plavix (Clopidogrel)-some genetic variability in metabolism• Effient (Prasugrel)-more effective than Plavix, but more bleeding, especially in older patients
    • Ticagrelor (Brilinta)• Reversible binding• May be slightly more effective than Plavix if used with small doses of ASA
    • Glycoprotein 2b/3a Receptor Antagonists• Abciximab (Reopro)• Eptifibatide (Integrilin)• Tirofiban (Aggrastat)• All given IV• Can see bleeding at puncture sites, can see serious Thrombocytopenia
    • Anticoagulants• Heparin-advantages-quick reversal, cheap, not cleared by kidneys. Disadvantages-need monitoring, more HIT• LMWH-enoxaparin (Lovenox) and dalteparin (Fragmin). At least as safe and effective as Heparin in ACS. Also effective for Venous thrombosis prevention and Rx.
    • Anticoagulants• Fondaparinux-(Arixtra)• As effective as LMWH in ACS except PCI• Once a day• Limited in renal insufficiency• Less likely to cause HIT
    • Oral Anticoagulants• Warfarin (Coumadin)• Vitamin K antagonist-Factors 2,7,9,10• Effective in VT, stroke prevention with A fib (more than anti platelet drugs)• Needs monitoring, can reverse with FFP and Vit K
    • Oral Anticoagulants-Pradaxa• Dabigatran• No monitoring• Irreversible, once a day (long acting)• Effective for VT and A fib• Direct Thrombin Inhibitor
    • Oral Anticoagulants-Xarelto• Rivaroxaban• Once daily• Irreversible, no monitoring• Seems at least as effective as Warfarin for VT and A fib• Direct Thrombin Inhibitor
    • Oral Anticoagulants-Eliquis• Apixaban• Yet to be approved by FDA• Maybe better than Warfarin in Afib and Lovenox in VT• May not help with ACS• Direct Thrombin Inhibitor
    • Direct Thrombin Inhibitors• Bivalirudin (Angiomax)• IV, short half life• Used instead of Heparin/LMWH in PCI. ? Maybe more effective with less bleeding
    • Issues• Cost• Lack of Monitoring• Study outcomes for ACS, PCI, VT prevention and Rx